[1] 王文，于红. 61例药物性肝病临床特点与转归分析[J]. 实用肝脏病杂志，2008，11（3）:191-192.
[2] WATKINS PB.Role of cytochromes p450 in drug metabolism and hepatotoxicity[J]. Semin Liver Dis，1990，10（4）:235-250.
[3] MICHAEL P，CYNTHIA JU.Mechanisms of drug-induced liver injury[J]. AAPS J，2006，8（1）:48-54.
[4] 陈成伟. 药物性肝病[J]. 肝脏，2004，9（1）:52-57.
[5] 陈树安. 细胞色素C在小鼠肝损伤及缺氧模型中的作用[J]. 沈阳医科大学学报，2002，19（1）:46-48.
[6] CASTELL JV，CASTELL M.Allergic hepatitis induced by drugs[J]. Curr Opin Allergy Clin Immunol，2006，6（4）:258-265.
[7] PAULI M，MEIER PJ.Hepatobiliary transports and drug-induced cholestasis[J]. Hepatology，2006，44（4）:778-787.
[8] ANDRADE RJ，LUCENA MI，ALONSO A，et a1.HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease[J]. Hepatology，2004，39（6）:1603-1612.
[9] MASAHITO N，MANABU T，AKIHIKO S，et a1.Interleukin-lO inhibits hepatic injury and tumor necrosis factor a and interferon-mRNA expression induced by staphylococcal enterotoxin B or lipolysaccharide in galactosamine-sensitized mice[J]. J Hepatol，1999，31（5）:71-80.
[10] SEHNYDER B，BURKHART C，SCHNYDER FK，et a1.Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+T cells from allergic individuals[J]. J Immunol，2000，164 （12）:6647-6649.
[11] FROMENTY B，PESSAYRE D.Inhibition of mitochondrial β-oxidation as a mechanism of hepatotoxicity[J]. Phsrmacol Ther，1995，67（2）:101-154.
[12] PESSAYRE D，BERSON A，FROMENTY B，et a1.Mitochondrial injury in steato hepatitis[J]. Eur J Gastroenterol Hepato，2004，16（11）:1095-1105.
[13] DELEVE LD，SHULMAN H，MEDONOLD GB.Toxic injury to hepatic sinusoids:sinusoidal obstruction syndrome（veno-occlusive disease）[J]. Semin Liver Dis，2002，22（1）:27-42.
[14] 陈成伟，缪晓辉. 细胞色素P450遗传多态性与药物性肝病[J]. 肝脏，2002，7（4）:263-264. |
